NCT06051552View on ClinicalTrials.gov

Prognostic Prediction Model in Patients With Moyamoya Disease Undergoing Revascularization Surgery

Not yet recruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions
Moyamoya Disease
Trial Locations (1)

Unknown

Capital Medical University, Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT06051552 - Prognostic Prediction Model in Patients With Moyamoya Disease Undergoing Revascularization Surgery | Biotech Hunter | Biotech Hunter